Advertisement
Australia markets close in 53 minutes

  • ALL ORDS

    7,838.80
    -98.70 (-1.24%)
     

  • ASX 200

    7,577.20
    -105.80 (-1.38%)
     

  • AUD/USD

    0.6533
    +0.0010 (+0.15%)
     

  • OIL

    83.87
    +0.30 (+0.36%)
     

  • GOLD

    2,347.90
    +5.40 (+0.23%)
     

  • Bitcoin AUD

    98,268.22
    +27.73 (+0.03%)
     

  • CMC Crypto 200

    1,385.51
    +2.94 (+0.21%)
     

  • AUD/EUR

    0.6090
    +0.0017 (+0.28%)
     

  • AUD/NZD

    1.0959
    +0.0002 (+0.02%)
     

  • NZX 50

    11,806.65
    -139.78 (-1.17%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    17,917.28
    -171.42 (-0.95%)
     

  • Hang Seng

    17,604.83
    +320.29 (+1.85%)
     

  • NIKKEI 225

    38,039.20
    +410.72 (+1.09%)
     

iCAD to Participate at the Imagine AI + Healthcare Investor Summit

icad inc.
·1-min read

NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, will present a corporate overview at Oppenheimer’s Imagine AI + Healthcare Investor Summit being hosted by Oppenheimer in partnership with the Alliance for AI in Healthcare (AAIH).

Oppenheimer’s Imagine AI + Healthcare Investor Summit
Date: Tuesday, December 7th
Time: 11:00 a.m. to 11:20 a.m. ET
Registration Link

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
britchie@lifesciadvisors.com